Recovery & Support for Dermatomyositis | NYU Langone Health
Doctors at NYU Langone provide follow-up care, annual screening tests, and mind-body wellness programs for people who have dermatomyositis.
A Phase 1/2 Study Evaluating the Safety and Efficacy of Amivantamab and Olomorasib Combination Therapy in Metastatic NSCLC KaRAnaSa (ISA-4)
This is a study in which patients have a specific change in their cancer cells called a KRAS G12C mutation, which means one tiny part of a gene (KRAS) has been changed in a way that may cause the cancer to grow. In this study, two medicines, Amivantamab and Olomorasib, are used together to treat this type of lung cancer (KRAS G12C-mutated metastatic NSCLC). Amivantamab is a special type of antibody that blocks two cancer related proteins (EGFR and MET) to stop cancer cell signaling. Olomorasib is an experimental medicine that blocks the KRAS G12C protein in cancer cells. This study consists of two parts: part one (combination dose selection) and part two (expansion). In Part one of the study, patients will be given the two medicines together to find the safest and most effective dose. Part two will see how well the two medicines work at the chosen dose to fight the cancer and slow down or prevent the growth of tumors. All patients will have frequent medical check ups and blood samples taken to see how their bodies are handling the study medicine. The study team will have special scans done for all patients to see how the cancer isresponding to the study medicines. The study team will be monitoring the patients for potential side effects and safety concerns.
mHealth-CArdiac REhabilitation for INOCA (INOCA-CARE)
This study will enroll participants with the condition condition called Ischemia with No-Obstructive Coronary Arteries (INOCA), which means the participant has "open arteries" (no major heart artery is blocked at least halfway). The purpose of this study is to find out if an exercise program done at home, called mobile health cardiac rehabilitation or mHealth-CR, can improve the health and quality of life of patients with INOCA. The purpose of this study is to find out if an exercise program done at home, called mobile health cardiac rehabilitation or mHealth-CR, can improve the health and quality of life of patients with INOCA. In order to understand if it does, we need to divide the participants into 2 groups, mHealth-CR group and usual care group, and compare the results. Both groups will receive the usual medical care determined by their doctor and will receive a Fitbit to track their activity. The main difference between the 2 groups is that only one group (the mHealth-CR group) will get access to the mHealth-CR app (Corrie health) on their mobile phone and will work with an exercise therapist who will create a personalized exercise plan to be followed for 3 months. Interested potential eligible participants will join a screening visit (remote) in which, if they agree to participate in the study, they will sign an informed consent form. After consent, the study participation will involve 2 in-person visits (at baseline and 3 months) and 2 virtual visits (at 6 and 12 months). For more information about the INOCA-CARE research study please send us a message here or email us at inoca@nyulangone.org.
Advanced Fetal Care Center | NYU Langone Health
Experts at NYU Langone’s Advanced Fetal Care Center provide pregnant women and their babies with advanced medical care.
Face Transplant Program | NYU Langone Health
NYU Langone’s Face Transplant Program offers an expert surgical and support team to reconstruct a range of facial disfigurements.
Adult Eating Disorders Program | NYU Langone Health
Specialists at NYU Langone Psychiatry Associates offer diagnosis and treatment for eating disorders in adults.
Geriatric Cardiology Program | NYU Langone Health
NYU Langone’s Geriatric Cardiology Program addresses the needs of older adults who have cardiovascular disease.
Watchful Waiting for Non-Hodgkin Lymphoma | NYU Langone Health
At NYU Langone, some slow-growing, or indolent, types of non-Hodgkin lymphoma may not require immediate treatment.
Bloodless Medicine & Surgery Program | NYU Langone Health
NYU Langone’s Bloodless Medicine and Surgery Program doctors use surgical and medical approaches to avoid using blood products during surgery.
Bone & Soft Tissue Tumor Program | NYU Langone Health
Specialists at NYU Langone’s Bone and Soft Tissue Tumor Program at Perlmutter Cancer Center treat all types of soft tissue and bone sarcomas.